Products include buffers, cell culture reagents, histology stains, immunology reagents, laboratory equipment, molecular biology reagents, solvents as well as many others
Sigma-Aldrich announces an agreement with MedAssets Supply Chain Systems to distribute its MedBasics products to MedAssets's customer base.
Established in 2004, the MedBasics product line consists of more than 3000 of the most popular products used by medical testing laboratories on a frequent basis as routine reagents.
Products include buffers, cell culture reagents, histology stains, immunology reagents, laboratory equipment, molecular biology reagents, solvents as well as many others.
"Sigma is extremely pleased to be able to meet both the specialty and routine chemistry and bioscience needs of MedAssets' members," said George Crowell, Sigma-Aldrich market segment manager.
"This is an excellent opportunity for Sigma to demonstrate its world-class quality, service and products to these customers".
Sigma-Aldrich describes itself as a leading life science and high technology company.
Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing.
The company has customers in life science companies, university and government institutions, hospitals, and in industry.
Over one million scientists and technologists use its products.
Sigma-Aldrich operates in 35 countries and has over 6800 employees providing excellent service worldwide.
MedAssets, headquartered in Atlanta, Georgia, says it improves healthcare providers' margin and cash flow through revenue cycle and supply chain initiatives.
As a strategic business partner, MedAssets says it can replace multiple vendors and decrease supply costs by 3-10% and increase net patient revenue by 1-3 %.
Proprietary information technology is used to work with and improve existing IT assets and work processes.
MedAssets, through its revenue cycle subsidiary MedAssets Net Revenue Systems, provides best-of-breed revenue solutions including strategic pricing, pre-bill charge capturing, and ongoing chargemaster management tools, all of which have been peer reviewed by the Healthcare Financial Management Association.
In addition, MedAssets offers the only technology enabled system that links supply cost data with charge data to ensure accurate charges and defendable markups for all patient identifiable supplies, including costly medical devices.
MedAssets, through its supply chain subsidiary MedAssets Supply Chain Systems, operates the fastest growing group purchasing organisation and supply chain services company in the USA and builds customised systems encompassing procurement of common medical supplies, pharmaceuticals, physician preference supplies, food and nutrition items, and capital equipment.
